Sexual health and emotional wellbeing of adolescent and young adult survivors of haematological malignancies.

Competing Interests: TA declares consulting fees from Biotest and Amgen; honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events from Biotest; receiving meeting or travel support from Biotest, Sandoz, Novartis, Astellas Pharma, and Viatris; and leadership or fiduciary roles for the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (unpaid, responsible for practice harmonisation group). MM declares grants or contracts (outside of the present Series papers) from Sanofi, Novartis, and Janssen; consulting fees from Adaptive Biotechnologies, Amgen, Astellas, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Jazz, Novartis, Pfizer, Sanofi, Stemline, and Takeda; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Adaptive Biotechnologies, Amgen, Astellas, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Jazz, Novartis, Pfizer, Sanofi, Stemline, Takeda, and MaaT; participation on a Data Safety Monitoring Board or Advisory Board for Janssen; and leadership or fiduciary role for European Society for Blood and Marrow Transplantation and the International Academy for Clinical Hematology. All other authors declare no competing interests.